Advertisement

Anemia

  • Gabrielle BergerEmail author
  • Ronald Huang
Chapter

Abstract

Preoperative and postoperative anemia are associated with increased morbidity and mortality after surgery. The goals of managing anemia in the perioperative setting include optimizing hemoglobin and hematocrit, preventing unnecessary blood loss, and using red blood cell transfusions judiciously. Recent studies indicate that adhering to a restrictive transfusion threshold (transfusion for hemoglobin <7–8 g/dL) in the perioperative setting does not impact morbidity and mortality and decreases patient exposure to RBC transfusion.

Keywords

Anemia Preoperative Postoperative Transfusion 

References

  1. 1.
    Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348(9034):1055–60.CrossRefGoogle Scholar
  2. 2.
    Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378(9800):1396–407.CrossRefGoogle Scholar
  3. 3.
    Carson JL, Noveck H, Berlin JA, et al. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002;42(7):812–8.CrossRefGoogle Scholar
  4. 4.
    Butcher A, Richards T. Cornerstones of patient blood management in surgery. Transfus Med. 2018;28(2):150–157. Open image in new window.CrossRefGoogle Scholar
  5. 5.
    Paone G, Likosky DS, Brewer R, et al. Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality. Ann Thorac Surg. 2014;97(1):87–93.CrossRefGoogle Scholar
  6. 6.
    Robich MP, Koch CG, Johnston DR, et al. Trends in blood utilization in United States cardiac surgical patients. Transfusion. 2015 Apr;55(4):805–14.CrossRefGoogle Scholar
  7. 7.
    Committee on Standards and Practice Parameters, Apfelbaum JL, Connis RT, Nickinovich DG, American Society of Anesthesiologists Task Force on Preanesthesia Evaluation, Pasternak LR, Arens JF, Caplan RA, et al. Practice advisory for preanesthesia evaluation: an updated report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology. 2012;116(3):522–38.CrossRefGoogle Scholar
  8. 8.
    National Institute for Health and Care Excellence (NICE). Routine preoperative tests for elective surgery. NICE guideline. 5 April 2016. Available at: nice.org.uk/guidance/ng45. Accessed 4 Apr 2018.
  9. 9.
    Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4(11):e524–33.CrossRefGoogle Scholar
  10. 10.
    Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999 Feb 11;340(6):409–17.CrossRefGoogle Scholar
  11. 11.
    American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on perioperative blood management. Anesthesiology. 2015;122(2):241–75.CrossRefGoogle Scholar
  12. 12.
    Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559–67.CrossRefGoogle Scholar
  13. 13.
    Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. FOCUS investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365:2453–62.CrossRefGoogle Scholar
  14. 14.
    Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157(1):49–58. Open image in new window.CrossRefGoogle Scholar
  15. 15.
    Carson JL, Stanworth SJ, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion (review). Cochrane Database Syst Rev. 2016;10:CD002042. Open image in new window.Google Scholar
  16. 16.
    Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive of Liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017;377:2133–44.CrossRefGoogle Scholar
  17. 17.
    ClinicalTrials.gov. National Library of Medicine (US). 2000 Feb 29. Myocardial Ischemia and Transfusion (MINT). Identifier NCT02981407. Accessed 5 Apr 2018. Available from: https://clinicaltrials.gov/ct2/show/NCT02981407.
  18. 18.
    Goodnough LT, Brecher ME, Kanter MH, et al. Transfusion medicine. First of two parts—blood transfusion. N Engl J Med. 1999;340(6):438–47.CrossRefGoogle Scholar
  19. 19.
    Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet. 2007;370(9585):415–26.CrossRefGoogle Scholar
  20. 20.
    Amin M, Fergusson D, Wilson K, et al. The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada. Transfusion. 2004;44(10):1479–86.CrossRefGoogle Scholar
  21. 21.
    Varney SJ, Guest JF. The annual cost of blood transfusions in the UK. Transfus Med. 2003;13(4):205–18.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Medicine, Division of General Internal MedicineUniversity of WashingtonSeattleUSA

Personalised recommendations